← Dataset search
T11, AT3, PyMT-M, 2208L GEMM tumors treated with H3B-8800
The objective is to identify splicing and expression changes that occur after spliceosome inhibition in triple-negative breast cancer using immune competent GEMM tumors.
Provenance — who produced it, who reused it
Linked to 1 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
Deposited / produced by
Jarey WangElizabeth BowlingThomas Westbrook
Reused by
- Spliceosome-targeted therapies trigger an antiviral immune respo... 2021 · 211 cites
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
Data type / assay
bulk-RNA-seq
Organism
Mus musculus
Instrument
NextSeq 500
Platform
ILLUMINA
Read type
short-read
Files available
FASTQ (raw reads)
N numbers (samples, groups)
25 / 25 runs
Completeness
100%
Metrics (value · how obtained)
checksum ok
yes
reported
total bases
105090303171
reported
total reads
705612456
reported
supplementary file types
GTF
reported
QC cost
6 s compute
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently